previous compound ID: 539 next compound
InChIKey: DYDCUQKUCUHJBH-UWTATZPHSA-N
SMILES: C1[C@H](C(=O)NO1)N

biological descriptors:

CFTR relevance: unspecified

Category:
Influence on CFTR function unknown
Order of interaction unknown
subcellular compartment unknown

reference list:

ReferenceID: 53
"JW Hanrahan" "D Rotin" "J Goepp" "SD Macknight" "E Matthes" "R Robert" "J Liao" "B Kus" "GW Carlile" "DY Thomas"

chemical graph of compound 539





CID is 6234
synonyms found at PubChem are:
D-cycloserine, cycloserine, 68-41-7, Seromycin, orientomycin, Oxamycin, Cyclorin, Cyclo-D-serine, Cicloserina, Farmiserina, Miroseryn, Tisomycin, Wasserina, Closina, D-4-amino-3-isoxazolidinone, (R)-4-AMINOISOXAZOLIDIN-3-ONE, alpha-Cycloserine, (+)-4-Amino-3-isoxazolidinone, Cycloserinum, Miroserina, D-4-amino-3-isoxazolidone, Oxamicina, PA 94, (+)-Cycloserine, (4R)-4-amino-1,2-oxazolidin-3-one, Oxamicina [Italian], Cycloserin, Micoserina, (4R)-4-aminoisoxazolidin-3-one, Cicloserina [Italian], PA-94, Tebemicina, Novoserin, D-Oxamycin, D-CS, Cycloserinum [INN-Latin], E-733-A, Cicloserina [INN-Spanish], (R)-4-AMINO-ISOXAZOLIDIN-3-ONE, D-4-Amino-3-isossazolidone, D-(+)-Cycloserine, RO-1-9213, 3-Isoxazolidinone, 4-amino-, (R)-, Closerin, HSDB 3218, D-Oxamicina, 3-Isoxazolidinone, 4-amino-, d-, (R)-Cycloserine, K-300, Seromycin (TN), UNII-95IK5KI84Z, R-4-Amino-3-isoxazolidinone, Cycloserine [INN:BAN:JAN], I-1431, 3-Isoxazolidinone, 4-amino-, (+)-, D-4-Amino-3-isossazolidone [Italian], NSC 154851, 3-Isoxazolidinone, 4-amino-, (4R)-, R-(+)-Cycloserine, (R)-4-Amino-3-isoxazolidinone, CHEBI:40009, AI3-50153, (4R)-4-Amino-3-isoxazolidinone, D-Cycloserine, synthetic, DRG-0195, (R)-(+)-Cycloserine, EINECS 200-688-4, D-amino-3-isoxazolidinone, CHEMBL771, BRN 0080798, SC-49088, (R)-4-Amino-3-isoxazolidone, 95IK5KI84Z, 3-Isoxazolidinone, 4-amino-, D, DYDCUQKUCUHJBH-UWTATZPHSA-N, R(+)-4-Amino-3-isoxazolidinone, 3-Isoxazolidinone, 4-amino-, (R), (R)-(+)-4-Amino-3-isoxazolidinone, CAS-68-41-7, NCGC00016306-01, DSSTox_CID_2870, 3-Isoxazolidinone, 4-amino-, (+)- (8CI), 3-Isoxazolidinone, 4-amino-, (4R)- (9CI), C 3909, C-9390, C-9400, DSSTox_RID_76766, DSSTox_GSID_22870, FA6C7F8B-D080-4EA3-978F-1ECFB5A29D09, Cycloserine (JP15/USP/INN), Cycloserine, D-, .alpha.-Cycloserine, 4AX, CPD000058313, SMR000058313, (S)-(-)-Cycloserine, 3-Isoxazolidinone, 4-amino-, (+)-(8CI), 3-isoxazolidinone, 4-amino-, (4r)-(9ci), 4-Amino-isoxazolidin-3-one, SR-01000075432, D-Cycloserine synth. BP 88, Serine, cyclo-, Cycloserine [USP:INN:BAN:JAN], PubChem5763, D-Cycloserine, powder, Spectrum_000860, 1pb9, CYCLOSERINE (D), Prestwick0_001089, Prestwick1_001089, Prestwick2_001089, Prestwick3_001089, Spectrum2_000084, Spectrum3_000371, Spectrum4_000305, Spectrum5_000797, Lopac-C-1159, Lopac-C-3909, Lopac-C-7005, D02WFK, D04TMQ, D0G6RT, AC1Q4UA7, Lopac0_000252, SCHEMBL34322, BSPBio_001138, BSPBio_002121, KBioGR_000890, KBioSS_001340, 4-27-00-05549 (Beilstein Handbook Reference), MLS000758215, MLS001423962, MLS002548887, BIDD:GT0707, DivK1c_000098, SPECTRUM1500215, SPBio_000008, SPBio_003029, AC1L1M33, BPBio1_001252, GTPL9489, Cycloserine (JP17/USP/INN), 4-Amino-3-isoxazolidinone, D-, DTXSID8022870, HMS500E20, KBio1_000098, KBio2_001340, KBio2_003908, KBio2_006476, KBio3_001341, MolPort-000-858-643, NINDS_000098, HMS1571I20, HMS1920C06, HMS2051C15, HMS2091I14, HMS2098I20, HMS2232F03, HMS3259L19, HMS3260D06, HMS3715I14, NJ-21, Pharmakon1600-01500215, R (+)-4-amino-3-isoxazolidinone, (R)-3-Isoxazolidinone, 4-amino-, 4-Amino-3-isoxazolidinone, (R)-, ACT04767, HY-B0030, KS-00001FB7, Tox21_110361, Tox21_500252, BDBM50038178, BDBM50103516, CCG-39705, D-Cycloserine, >=96.0% (NT), FC1270, LMPK14000007, MFCD00005353, NSC756712, s1998, ZINC34676245, (R)-4-amino-1,2-oxazolidin-3-one, 4-Isoxazolidinamine, 3-oxo-, (D)-, AKOS015994626, Tox21_110361_1, AC-4721, CS-2395, DB00260, HS-0079, LP00252, MCULE-4212827696, NC00050, NC00676, NSC-756712, RL04615, IDI1_000098, SMP1_000167, NCGC00015213-01, NCGC00015213-02, NCGC00015213-03, NCGC00016306-02, NCGC00016306-03, NCGC00016306-04, NCGC00016306-05, NCGC00016306-07, NCGC00016306-08, NCGC00093713-01, NCGC00093713-02, NCGC00260937-01, AJ-89953, AN-11678, BR-26256, CAS-339-72-0, K138, KB-49618, LS-86757, SAM001247014, SAM002264599, SC-06256, ST075697, SBI-0050240.P004, AB0007232, AB2000415, ST2408171, AB00443920, EU-0100252, FT-0624464, (4R)-4-amino-2,4,5-trihydroisoxazol-3-one, C08057, D00877, AB00443920_09, AB00443920_10, 005C353, 101039-EP2295402A2, 101039-EP2301544A1, SR-01000759389, SR-01000075432-1, SR-01000075432-2, SR-01000075432-5, SR-01000075432-9, SR-01000759389-4, SR-01000075432-10, F2173-1228, Z1522567171, Cycloserine, United States Pharmacopeia (USP) Reference Standard, Cycloserine, Pharmaceutical Secondary Standard; Certified Reference Material, cycloserine zwitterion, D-cycloserine zwitterion, alpha-cycloserine zwitterion, CHEBI:74159, D-4-amino-3-isoxazolidinone zwitterion, CJ-18543, (+)-4-amino-3-isoxazolidinone zwitterion, (4R)-4-aminoisoxazolidin-3-one zwitterion, (4R)-4-ammonio-4,5-dihydroisoxazol-3-olate, (4R)-4-ammonio-3-oxo-1,2-oxazolidin-2-ide, A836140, (4R)-4-azaniumyl-4,5-dihydro-1,2-oxazol-3-olate